All Episodes
Displaying episodes 61 - 83 of 83 in total
Hand Foot Skin Reaction - A Painful Chemotherapy Side Effect - Could There Be a Treatment?? Dr. Mike McCullar, CEO of OnQuality Pharmaceuticals
A side effect of chemotherapy, where hands and feet may be raw, painful, and immobilized. With no current treatment, a new candidate has just finished Phase II clinica...
Can the Mapping of Human Biology Lead to Better Drugs? Dr. Chris Gibson, Co-Founder & CEO Recursion Pharmaceuticals
Dr. Chris Gibson, the co-founder and CEO of Recursion Pharmaceuticals in Salt Lake City. We talk about their efforts to map ALL of human biology, and how this mapping ...
Has Medtech Excluded Persons of Color & Women?? Dr. Patrice Matchaba President, Novartis US Foundation
Dr. Patrice Matchaba, the President of the Novartis US Foundation, shows us how medical technology can create systemic racism, both in the medical field and in human c...
Safe NON-OPIOID Pain Relief - Is It Possible? Dr. Hernan Bazan, Co-Fdr & CEO, South Rampart Pharma
The next generation of pain relief – non-opioid pain relief - with the goal of being equally powerful pain relief without addiction. Dr Hernan Bazan is the Co-Founder ...
Long Covid related to Fibromyalgia? Dr. Seth Lederman, Tonix Pharmaceuticals
Dr. Seth Lederman, Co-Founder and CEO of Tonix Pharmaceuticals, tells us that Long Covid may be related to Fibromyalgia. Now recruiting in advanced Human Clinical Tria...
The Oxford Dodo? ... Joe Hernandez, Blue Water Vaccines
Even Saturday Night Live couldn’t resist the story of a “genetics engineering company” trying to de-extinct the dodo bird. Blue Water Vaccines, founder and CEO Joe Her...
Getting Immune Systems to Recognize HER2+ tumors - Dr. Randy Schatzman, President & CEO, Bolt Biotherapeutics
Bolt Biotherapeutics’ Dr. Randy Schatzman talks about the role of myeloid cells in teaching our immune systems to recognize tumors in our own bodies and then eliminate...
22-45 Getting a Vaccination? What about a nasal spray?
Dr. Robert Coleman, the Co-Founder and CEO of Codagenix, shows us how to precisely engineer viruses to be effective vaccines, which can be delivered nasally – you hear...
23-04 Sir Rory Collins, Oxford Professor and Principal Investigator, UK Biobank
Sir Rory Collins is a Professor of Medicine and Epidemiology at the University of Oxford and the Principal Investigator of the UK Biobank. With data from half a millio...
23-03 Dr. Rob Ross, CEO, Surface Oncology
Surface Oncology's strategy to improve on the first generation of immuno-oncology drugs. Their Phase 2 trials in lung cancer and liver cancer are underway and recruiting.
Antidepressants Should Have Diagnostics???
Major Depressive Disorder. Serious Depression. PTSD. Alto Neuroscience CEO, Dr. Amit Etkin talks about developing new and innovative drugs tied directly to each patien...
23-01 Gene Kinney, President & CEO, Prothena Biosciences
Prothena's 1-2-3 punch for Alzheimer’s + their work in Parkinson’s, ALS, and the role of Amyloids in Down Syndrome
22-52 Edward Humes, Pulitzer Prize Winner, "The Forever Witness"
In a long-form feature from Tech Nation, it’s Pulitzer Prize-winning author, Edward Humes, with “The Forever Witness … How DNA and Genealogy Solved a Cold Case Double ...
22-51 Keven Ali, CEO, Organon
A new global company with 64 products, many of which are for women? Kevin Ali is the CEO of Organon.
22-50 Dr. Steve Worland, Co-Founder & CEO, eFFECTOR Therapeutics
Cancer is a hijacker, hijacking cells for its own purposes. And that’s where eFFECTOR Therapeutics is determined to intervene. Dr. Steve Worland, the Co-Founder & CEO,...
22-49 Dr. Zandy Forbes, Pres & CEO, MeiraGTx
Like the idea of replacing some of your DNA with DNA that works better? And what if you want that new DNA to stop? Dr. Alexandria Forbes, the President & CEO of MeiraG...
22-48 Dr. Robert Ang, President & CEO, Vor Biopharma
Vor Biopharma has a unique approach to a particular kind of cancer – Acute Myeloid Leukemia – perhaps better known to you, as AML. Dr. Robert Ang is Vor's President & ...
22-47 Dr. James Mackay, President & CEO, Aristea Therapeutics
Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's c...
22-46 Dr. Maria Maccecchini, Founder, President & CEO, Annovis Bio
Alzheimer’s, Parkinson’s and ALS, among others, are often grouped as Neurodegenerative Disorders. While they each present a different profile of symptoms, what do they...
22-16 Triple-Negative Breast Cancer is the most aggressive of all
Anixa is pioneering a new approach to preventing the truly aggressive triple-negative form of breast cancer. Based on research from Cleveland Clinic, this approach has...
Dr. George Yancopoulos, CEO, Regeneron
Dr. George Yancopoulosis is the President and Chief Scientific Officer of Regeneron. Regeneron is successful on many levels but is perhaps best known for its Covid tre...
Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics
Blood clots of any sort are dangerous. So dangerous in fact, that 1 in 4 people die from blood clots - independent of medical condition, medicines they take, or medica...
Mark Litton, President & CEO, Athira Pharma
Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natura...